Uteron Pharma : Research for woman future
> Products > Levosert™
Uteron Pharma : Research for woman future

2013/01/23 : Watson Acquires Uteron Pharma

Read more


2012/05/2 : Uteron Pharma is contemplating a public offering to finance the (...)

Read more


2012/04/24 : Professor Jean-Michel Foidart has been awarded the Bologne-Lemaire (...)

Read more



Uteron Pharma : Research for woman future

Levosert™

Levosert hormonal intra-uterine device (IUD) is a flexible frame which consistently releases small quantities of levonorgestrel in the uterine cavity.

More than 150 million women worldwide use an IUD, more than any other contraceptive method. Most IUDs in use are copper based, which has been available for decades, and generally provide contraception for five to ten years through the release (of different quantities) of copper particles. Copper IUDs are in most countries not considered as pharmaceutical but rather as medical device. Copper IUDs are widely available worldwide and a large number of players are currently active. Hormonal IUDs are complex pharmaceuticals, hence the limited number of products available.

 



© 2011 Uteron Pharma - Legal - Privacy policy Designed and Powered by Lusis Communication

Company

Background
History
Location
Contact us

Products

Levosert™
Diafert™

Production

Market

Newsroom

Uteron Pharma : Research for woman future